RNA Edge System

Optimizing expression of RNA therapies. Go from sequence to validated candidates in a matter of weeks.

ACCELERATING RNA THERAPEUTICS

A lab-in-the-loop platform for AI optimization of RNA therapies

Applications

Expression profile is a primary determinant of therapeutic success, but most RNA sequences are still optimized using outdated single-variable approaches, leaving significant performance potential unrealized. Achieving high expression and durability requires balancing multiple interdependent factors simultaneously: translation dynamics, RNA secondary structure, and genetic element interactions.

RNA Edge was built to solve this multi-dimensional design problem. It's a fully integrated system for optimization of expression profile, with every design validated in application-relevant cell types.

We deliver high-confidence RNA designs in weeks.

Benefits of RNA Edge

Antibody

End-to-end RNA optimization

  • AI sequence optimization, novel genetic parts, and experimental validation to improve expression profile.
Virus

Broad therapeutic applicability

  • Supports linear mRNA and circular RNA across cell therapy, genome editing, and vaccines.
Strand of DNA

Proven performance

  • Validated in large biopharma programs for CAR and Cas9.

System performance

Data-driven computational and synthetic biology, validated in the lab.

RNA Edge combines proprietary computational models and high-performance genetic parts with integrated screening to deliver validated improvements across the variables that determine therapeutic success.

From sequence to delivery of top candidates

RNA Edge takes your program from sequence design through wet lab validation in weeks, delivering high confidence, data-backed candidates.

Contact us

Ready to optimize your RNA 
therapeutic?

Country
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
CONTACT US

We're hiring at the intersection of biology, engineering, and machine learning.

Asimov team at their Boston office
Illustration of a white blood cell
SYSTEM CAPABILITIES

Precise control to drive therapeutic success

Expression profile is a primary determinant of therapeutic success, but achieving the right level, timing, and cell specificity requires optimizing across multiple interdependent biological factors simultaneously. RNA Edge combines proprietary computational models, high-performance genetic parts, and integrated lab screening to systematically explore design space and deliver high-performing candidates across every axis of expression.

Key capabilities

Antibody

Multi-objective codon optimization

  • Up to 9x higher expression by optimizing multiple biological factors.

Virus

Genetic parts

  • Internal ribosome entry site (IRES) and untranslated region (UTR) design and screening capabilities.
Strand of DNA

Validation in relevant cells

  • Integrated in vitro screening in application-relevant cell models provides greater insight into real-world therapeutic performance.

Why choose RNA Edge?

Models: Proprietary RNA sequence optimization

Traditional codon optimization approaches are simplistic and frequently underperform. Our algorithm balances multiple factors in parallel: translational dynamics, synthesizability, RNA stability, and motif avoidance, to generate sequences with a more complete and balanced expression profile.

Genetic parts: AI-driven 5'UTR design

RNA Edge applies AI-driven design and screening to untranslated regions (UTRs), generating 5'UTRs de novo and evolving existing sequences to optimize linear mRNA expression. Most designs outperform the commonly used human beta-globin (HBB) control, with the best reaching up to 2.9-fold higher expression.

Genetic parts: High-performance IRES elements

Off-the-shelf internal ribosome entry site (IRES) elements deliver over 4x higher expression than industry standards, supporting circular RNA and multi-transgene constructs.

Lab capabilities: Rapid production and screening

Design flows seamlessly into production, screening, and validation under one roof. Sequence variants are tested in application-relevant cell-based assays, enabling faster design decisions that reflect real-world therapeutic context. Our production and screening capabilities include DNA template generation, RNA generation and purification, cell-based screening and validation, and analytical methods.

Optimization outcomes

Antibody

Expression level

  • Increased expression to achieve the optimal profile.
Virus

Duration and stability

  • Greater control over RNA half-life and temporal dynamics.
Strand of DNA

Cell type expression profiling

  • Exploration and understanding of differential expression across cell types.

How it works

RNA Edge is an end-to-end integrated platform that delivers top candidates in weeks.

1

Chris Voigt at his MIT laboratory

AI-guided sequence optimization

Variants generated using Asimov’s proprietary machine learning models, multi-objective codon optimizer, and genetic parts.

2

Chris Voigt at his MIT laboratory

RNA production

Integrated production and purification of RNA sequence variants.

3

Chris Voigt at his MIT laboratory

Hit generation primary screen

All variants screened in cell-based assays. Top candidates nominated.

4

Chris Voigt at his MIT laboratory

Hit-to-lead validation screen

Top hits validated with concentration dependent expression profiling.

5

Chris Voigt at his MIT laboratory

Delivery of optimized candidates

Optimized sequences transferred with full data package, ready for your next stage.

Contact us

Ready to optimize your RNA 
therapeutic?

Country
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form